logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Moritz Fürstenau

University of Cologne
H指数:18
被引数:1,274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

更正：携带t(14;19)易位的慢性淋巴细胞白血病患者临床和转录组学特征：一项ERIC研究

Leukemia
IF13.4
2026-10-160
OAAI
Andrea Visentin; Enrico Gaffo; Moritz Fürstenau; Kerry A. Rogers; Baliakas Panagiotis; Chenghua Cui; Cecelia Miller; Claudia Haferlach; Karla Plevova; David Oscier; Zadie Davis; Florence Nguyen-Khac; Eleonora Roncaglia; Gian Matteo Rigolin; Anastasia Athanasiadou; Fanny Baran-Marszak; Alberto Valiente; Maria José Terol; Pau Abrisqueta; Blanca Espinet; Anna Puiggros; Annalisa Martines; Laura Bonaldi; Francesca Romana Mauro; Lydia Scarfò; Thomas Chatzikonstantinou; Eugen Tausch; Karl-Anton Kreuzer; Arnon P. Kater; Francesc Bosch; Michael Doubek; Panagiotis Panagiotidis; Olga Kalashnikova; Federica Frezzato; Giulia Calabretto; Valeria Ruocco; Silvia Orsi; Alessandro Cellini; Francesco Angotzi; Andrea Serafin; Shuhua Yi; Barbara Eichhorst; Jennifer A. Woyach; Antonio Cuneo; Paolo Ghia; Kostas Stamatopoulos; Livio Trentin; Stefania Bortoluzzi
Time-limited venetoclax combinations in untreated chronic lymphocytic leukemia: Five-year results and patient-reported outcome analysis of the randomized phase 3 CLL13/GAIA trial

限时Venetoclax联合疗法在初治慢性淋巴细胞白血病中的应用：CLL13/GAIA随机III期试验的五年结果及患者报告结局分析

Blood
IF23.1
2026-04-010
PRE
Moritz Fürstenau; Carsten U. Niemann; Sandra Robrecht; Emelie C. Rotbain; Laura Eurelings; Adam Giza; Julia von Tresckow; Can Zhang; Michael Gregor; Patrick Thornton; Philipp B. Staber; Tamar Tadmor; Vesa Lindström; Gunnar Juliusson; Ann Janssens; Caspar da Cunha-Bang; Christof Schneider; Yair Herishanu; Derville O’Shea; Michael Baumann
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

携带t(14;19)易位的慢性淋巴细胞白血病患者临床及转录组学特征：一项ERIC研究

Leukemia
IF13.4
2025-09-190
OAAI
Andrea Visentin; Enrico Gaffo; Moritz Fürstenau; Kerry A. Rogers; Baliakas Panagiotis; Chenghua Cui; Cecelia Miller; Claudia Haferlach; Karla Plevova; David Oscier; Zadie Davis; Florence Nguyen-Khac; Eleonora Roncaglia; Gian Matteo Rigolin; Anastasia Athanasiadou; Fanny Baran-Marszak; Alberto Valiente; Maria José Terol; Pau Abrisqueta; Blanca Espinet; Anna Puiggros; Annalisa Martines; Laura Bonaldi; Francesca Romana Mauro; Lydia Scarfò; Thomas Chatzikonstantinou; Eugen Tausch; Karl-Anton Kreuzer; Arnon Kater; Francesc Bosch; Michael Doubek; Panagiotis Panagiotidis; Olga Kalashnikova; Federica Frezzato; Giulia Calabretto; Valeria Ruocco; Silvia Orsi; Alessandro Cellini; Francesco Angotzi; Andrea Serafin; Shuhua Yi; Barbara Eichhorst; Jennifer A. Woyach; Antonio Cuneo; Paolo Ghia; Kostas Stamatopoulos; Livio Trentin; Stefania Bortoluzzi
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

Acalabrutinib治疗≥80岁及/或虚弱慢性淋巴细胞白血病患者：CLL-Frail试验主要终点分析

Blood
IF23.1
2025-09-080
OAAI
Florian Simon; Rudy Ligtvoet; Jan-Paul Bohn; Thomas Nösslinger; Julia von Tresckow; Rüdiger Liersch; Tobias Gaska; Kathleen Jentsch-Ullrich; Michael Gärtner; Thomas Wolff; Ingo Schwaner; Dominik Wolf; Christof Schneider; Ursula Vehling-Kaiser; Matthias Ritgen; Christian Spoer; Michael Eckart; Thomas Decker; Geothy Chakupurukal; Björn Schöttker; Jens Kisro; Karl-Anton Kreuzer; Eugen Tausch; Stephan Stilgenbauer; Sandra Robrecht; Janina Stumpf; Anna-Maria Fink; Moritz Fürstenau; Kirsten Fischer; Valentin Goede; Michael Hallek; Barbara Eichhorst
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

维奈克拉-obinutuzumab在CLL中，体能和剂量强度对临床结局的影响

Blood
IF23.1
2025-08-290
OAAI
Othman Al-Sawaf; Moritz Fürstenau; Adam Giza; Sandra Robrecht; Julia von Tresckow; Anna-Maria Fink; Florian Simon; Eugen Tausch; Christof Schneider; Liliya Sivcheva; Anthony Schwarer; Javier Loscertales; Robert Weinkove; Dirk Strumberg; Allanah Kilfoyle; Gunnar Juliusson; Caspar da Cunha-Bang; Thomas Illmer; Michael Gregor; Patrick Thornton
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

维奈克拉-奥比妥珠单抗在CLL中，体能和剂量强度对临床结局的影响

Blood
IF23.1
2025-08-290
OAAI
Othman Al-Sawaf; Moritz Fürstenau; Adam Giza; Sandra Robrecht; Julia von Tresckow; Anna-Maria Fink; Florian Simon; Eugen Tausch; Christof Schneider; Liliya Sivcheva; Anthony Schwarer; Javier Loscertales; Robert Weinkove; Dirk Strumberg; Allanah Kilfoyle; Gunnar Juliusson; Caspar da Cunha-Bang; Thomas Illmer; Michael Gregor; Patrick Thornton
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

MRD指导下的zanubrutinib、venetoclax和obinutuzumab在复发性CLL中的应用：CLL2-BZAG试验的主要终点分析

BLOOD
IF23.1
2025-01-301
PRE
Fuerstenau, Moritz; Robrecht, Sandra; Schneider, Christof; Tausch, Eugen; Giza, Adam; Ritgen, Matthias; Bittenbring, Joerg; Hebart, Holger; Schoettker, Bjoern; Illert, Anna Lena; Graeven, Ullrich; Stoltefuss, Andrea; Heinrich, Bernhard; Eckert, Robert; Fink, Anna; Stumpf, Janina; Fischer, Kirsten; Al-Sawaf, Othman; Simon, Florian; Kleinert, Fanni; Weiss, Jonathan; Kreuzer, Karl-Anton; Schilhabel, Anke; Brueggemann, Monika; Langerbeins, Petra; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Cramer, Paula
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-05-170
OAAI
Langerbeins, Petra; Giza, Adam; Robrecht, Sandra; Cramer, Paula; von Tresckow, Julia; Al-Sawaf, Othman; Fink, Anna Maria; Fuerstenau, Moritz; Kater, Arnon; van der Spek, Ellen; Niemann, Carsten Utoft; da Cunha-Bang, Caspar; Tausch, Eugen; Schneider, Christof; Stilgenbauer, Stephan; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

慢性淋巴细胞白血病患者新型冠状病毒肺炎和COVID后病情的演变: 欧洲CLL研究计划ERIC的一项研究

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2023-09-2911
OAAI
Visentin, Andrea; Chatzikonstantinou, Thomas; Scarfo, Lydia; Kapetanakis, Anargyros; Demosthenous, Christos; Karakatsoulis, Georgios; Minga, Eva; Chamou, Dimitra; Allsup, David; Cabrero, Alejandro Alonso; Andres, Martin; Antic, Darko; Baile, Monica; Baliakas, Panagiotis; Besikli-Dimou, Sotiria; Bron, Dominique; Chatzileontiadou, Sofia; Cordoba, Raul; Correa, Juan-Gonzalo; Cuellar-Garcia, Carolina; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Delgado, Julio; Dimou, Maria; Donaldson, David; Catherwood, Mark; Doubek, Michael; Efstathopoulou, Maria; Eichhorst, Barbara; Elashwah, Salma; Enrico, Alicia; Espinet, Blanca; Farina, Lucia; Ferrari, Angela; Foglietta, Myriam; Frederiksen, Henrik; Furstenau, Moritz; Garcia-Marco, Jose A.; Garcia-Serra, Rocio; Collado, Rosa; Gentile, Massimo; Gimeno, Eva; Glenthoj, Andreas; da Silva, Maria Gomes; Hakobyan, Yervand K.; Herishanu, Yair; Hernandez-Rivas, Jose Angel; Herold, Tobias; Innocenti, Idanna; Itchaki, Gilad; Jaksic, Ozren; Janssens, Ann; Kalashnikova, Olga B.; Kalicinska, Elzbieta; Kater, Arnon P.; Kersting, Sabina; Labrador, Jorge; Lad, Deepesh; Laurenti, Luca; Levin, Mark-David; Lista, Enrico; Lopez-Garcia, Alberto; Malerba, Lara; Marasca, Roberto; Marchetti, Monia; Marquet, Juan; Mattsson, Mattias; Mauro, Francesca R.; Morawska, Marta; Motta, Marina; Munir, Talha; Murru, Roberta; Niemann, Carsten U.; Rodrigues, Raquel Nunes; Olivieri, Jacopo; Orsucci, Lorella; Papaioannou, Maria; Pavlovsky, Miguel Arturo; Piskunova, Inga; Popov, Viola Maria; Quaglia, Francesca Maria; Quaresmini, Giulia; Qvist, Kristian; Rigolin, Gian Matteo; Ruchlemer, Rosa; Simkovic, Martin; Spacek, Martin; Sportoletti, Paolo; Stanca, Oana; Tadmor, Tamar; Capasso, Antonella; Del Poeta, Giovanni; Gutwein, Odit; Karlsson, Linda Katharina; Milosevic, Ivana; Miras, Fatima; Reda, Gianluigi; Saghumyan, Gevorg; Shrestha, Amit; Raa, Doreen Te; Tonino, Sanne H.; Van Der Spek, Ellen; van Gelder, Michel; van Kampen, Roel; Wasik-Szczepanek, Ewa; Wrobel, Tomasz; San Segundo, Lucrecia Yanez; Yassin, Mohamed; Pocali, Barbara; Vandenberghe, Elisabeth; Iyengar, Sunil; Varettoni, Marzia; Vitale, Candida; Coscia, Marta; Rambaldi, Alessandro; Montserrat, Emili; Cuneo, Antonio; Stavroyianni, Niki; Trentin, Livio; Stamatopoulos, Kostas; Ghia, Paolo
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-05-11124
PRE
Eichhorst, Barbara; Niemann, Carsten U.; Kater, Arnon P.; Fuerstenau, Moritz; von Tresckow, Julia; Zhang, Can; Robrecht, Sandra; Gregor, Michael; Juliusson, Gunnar; Thornton, Patrick; Staber, Philipp B.; Tadmor, Tamar; Lindstrom, Vesa; da Cunha-Bang, Caspar; Schneider, Christof; Poulsen, Christian B.; Illmer, Thomas; Schoettker, Bjoern; Noesslinger, Thomas; Janssens, Ann; Christiansen, Ilse; Baumann, Michael; Frederiksen, Henrik; van der Klift, Marjolein; Jaeger, Ulrich; Leys, Maria B. L.; Hoogendoorn, Mels; Lotfi, Kourosh; Hebart, Holger; Gaska, Tobias; Koene, Harry; Enggaard, Lisbeth; Goede, Jereon; Regelink, Josien C.; Widmer, Anouk; Simon, Florian; De Silva, Nisha; Fink, Anna-Maria; Bahlo, Jasmin; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl A.; Ritgen, Matthias; Brueggemann, Monika; Tausch, Eugen; Levin, Mark-David; van Oers, Marinus; Geisler, Christian; Stilgenbauer, Stephan; Hallek, Michael
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial
LANCET HAEMATOLOGY
IF17.7
2022-10-019
PRE
Cramer, Paula; Furstenau, Moritz; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fink, Anna-Maria; Fischer, Kirsten; Langerbeins, Petra; Al-Sawaf, Othman; Tausch, Eugen; Schneider, Christof; Schetelig, Johannes; Dreger, Peter; Bottcher, Sebastian; Kreuzer, Karl-Anton; Schilhabel, Anke; Ritgen, Matthias; Bruggemann, Monika; Kneba, Michael; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
LEUKEMIA
IF13.4
2022-06-254
OAAI
von Tresckow, Julia; Cramer, Paula; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Fuerstenau, Moritz; Illmer, Thomas; Klaproth, Holger; Tausch, Eugen; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

CLL患者的新型冠状病毒肺炎严重程度和死亡率: 国际ERIC和CLL研究的最新进展

LEUKEMIA
IF13.4
2021-11-0169
OAAI
Chatzikonstantinou, Thomas; Kapetanakis, Anargyros; Scarfo, Lydia; Karakatsoulis, Georgios; Allsup, David; Alonso Cabrero, Alejandro; Andres, Martin; Antic, Darko; Baile, Monica; Baliakas, Panagiotis; Bron, Dominique; Capasso, Antonella; Chatzileontiadou, Sofia; Cordoba, Raul; Correa, Juan-Gonzalo; Cuellar-Garcia, Carolina; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Demosthenous, Christos; Dimou, Maria; Donaldson, David; Doubek, Michael; Efstathopoulou, Maria; Eichhorst, Barbara; El-Ashwah, Shaimaa; Enrico, Alicia; Espinet, Blanca; Farina, Lucia; Ferrari, Angela; Foglietta, Myriam; Frederiksen, Henrik; Furstenau, Moritz; Garcia-Marco, Jose A.; Garcia-Serra, Rocio; Gentile, Massimo; Gimeno, Eva; Glenthoj, Andreas; da Silva, Maria Gomes; Gutwein, Odit; Hakobyan, Yervand K.; Herishanu, Yair; Angel Hernandez-Rivas, Jose; Herold, Tobias; Innocenti, Idanna; Itchaki, Gilad; Jaksic, Ozren; Janssens, Ann; Kalashnikova, Olga B.; Kalicinska, Elzbieta; Karlsson, Linda Katharina; Kater, Arnon P.; Kersting, Sabina; Labrador, Jorge; Lad, Deepesh; Laurenti, Luca; Levin, Mark-David; Lista, Enrico; Lopez-Garcia, Alberto; Malerba, Lara; Marasca, Roberto; Marchetti, Monia; Marquet, Juan; Mattsson, Mattias; Mauro, Francesca R.; Milosevic, Ivana; Miras, Fatima; Morawska, Marta; Motta, Marina; Munir, Talha; Murru, Roberta; Niemann, Carsten U.; Rodrigues, Raquel Nunes; Olivieri, Jacopo; Orsucci, Lorella; Papaioannou, Maria; Arturo Pavlovsky, Miguel; Piskunova, Inga; Popov, Viola Maria; Quaglia, Francesca Maria; Quaresmini, Giulia; Qvist, Kristian; Reda, Gianluigi; Rigolin, Gian Matteo; Ruchlemer, Rosa; Saghumyan, Gevorg; Shrestha, Amit; Simkovic, Martin; Spacek, Martin; Sportoletti, Paolo; Stanca, Oana; Stavroyianni, Niki; Tadmor, Tamar; Te Raa, Doreen; Tonino, Sanne H.; Trentin, Livio; Van der Spek, Ellen; van Gelder, Michel; van Kampen, Roel; Varettoni, Marzia; Visentin, Andrea; Vitale, Candida; Wasik-Szczepanek, Ewa; Wrobel, Tomasz; Yanez San Segundo, Lucrecia; Yassin, Mohamed; Coscia, Marta; Rambaldi, Alessandro; Montserrat, Emili; Foa, Robin; Cuneo, Antonio; Stamatopoulos, Kostas; Ghia, Paolo
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
LEUKEMIA
IF13.4
2020-06-2938
OAAI
Fuerstenau, Moritz; Langerbeins, Petra; De Silva, Nisha; Fink, Anna Maria; Robrecht, Sandra; von Tresckow, Julia; Simon, Florian; Hohloch, Karin; Droogendijk, Jolanda; van der Klift, Marjolein; van der Spek, Ellen; Illmer, Thomas; Schoettker, Bjoern; Fischer, Kirsten; Wendtner, Clemens M.; Tausch, Eugen; Stilgenbauer, Stephan; Niemann, Carsten U.; Gregor, Michael; Kater, Arnon P.; Hallek, Michael; Eichhorst, Barbara
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
HAEMATOLOGICA
IF7.9
2020-02-2715
OAAI
Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
LEUKEMIA
IF13.4
2019-11-147
PREAI
Fuerstenau, Moritz; Hopfinger, Georg; Robrecht, Sandra; Fink, Anna-Maria; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Von Tresckow, Julia; Maurer, Christian; Kutsch, Nadine; Hoechstetter, Manuela; Dreyling, Martin; Lange, Elisabeth; Kneba, Michael; Stilgenbauer, Stephan; Doehner, Hartmut; Hensel, Manfred; Kiehl, Michael G.; Jaeger, Ulrich; Wendtner, Clemens-Martin; Goede, Valentin; Fischer, Kirsten; von Bergwelt-Baildon, Michael; Eichhorst, Barbara; Hallek, Michael; Theurich, Sebastian

研究方向

暂未获取到该数据
B
Barbara Eichhorst
H 指数:62论文数:439被引数:2.1万
M
Michael Hallek
H 指数:124论文数:1,647被引数:7.1万
J
Julia von Tresckow
H 指数:20论文数:104被引数:2,792
S
Sandra Robrecht
H 指数:30论文数:152被引数:3,827
K
Kirsten Fischer
H 指数:48论文数:389被引数:1.5万
E
Eugen Tausch
H 指数:40论文数:316被引数:8,796
S
Stephan Stilgenbauer
H 指数:126论文数:1,220被引数:7.3万
O
Othman Al‐Sawaf
H 指数:34论文数:184被引数:6,458
C
Christof Schneider
H 指数:34论文数:172被引数:4,969
P
Paula Cramer
H 指数:31论文数:177被引数:6,843